home / stock / tenx / tenx news


TENX News and Press, Tenax Therapeutics Inc. From 02/09/24

Stock Information

Company Name: Tenax Therapeutics Inc.
Stock Symbol: TENX
Market: NASDAQ
Website: tenaxthera.com

Menu

TENX TENX Quote TENX Short TENX News TENX Articles TENX Message Board
Get TENX Alerts

News, Short Squeeze, Breakout and More Instantly...

TENX - US Companies Moving the Markets, Morning edition
Fri, Feb 09, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States NanoString Technologies Inc. (NSTG) rose 118.4% to $0.1162 on volume of 394,556,402 shares U Power Limited (UCAR) rose 45.5% to $0.0959 on volume of 274,384,293 shares Palantir Technologies Inc. Class A (PLTR) rose 3.9% to $24.51 on v...

TENX - US Companies Moving the Markets, Evening edition
Thu, Feb 08, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States NanoString Technologies Inc. (NSTG) rose 164.5% to $0.1407 on volume of 378,097,862 shares U Power Limited (UCAR) rose 55.6% to $0.102517 on volume of 264,170,127 shares Palantir Technologies Inc. Class A (PLTR) rose 5.8% to $24.965 o...

TENX - TENX, PBM and PRSO among pre-market losers

2024-02-08 08:53:33 ET More on Pre-market losers & stocks. Peraso Inc. (PRSO) Q3 2023 Earnings Call Transcript Tenax surges after patent win for heart failure therapy Peraso to raise ~$4M through underwritten public offering of shares and warrants Financi...

TENX - Tenax Therapeutics stock sinks after it prices its public offering

2024-02-08 08:44:05 ET More on Tenax Therapeutics Tenax surges after patent win for heart failure therapy Tenax falls as rally driven by IND clearance cools Read the full article on Seeking Alpha For further details see: Tenax Therapeutics stock sinks aft...

TENX - Tenax Therapeutics Announces Pricing of Approximately $9 Million Public Offering

CHAPEL HILL, N.C., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, announced today th...

TENX - Tenax Therapeutics Enrolls First Patient in Phase 3 LEVEL Study Evaluating TNX-103 (Oral Levosimendan) for the Treatment of Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

Over 40 sites (U.S. and Canada) have agreed to participate in the LEVEL study LEVEL is a randomized, controlled Phase 3 trial of 152 patients, and will recruit patients primarily from leading research centers with large PH-HFpEF populations Tenax forecasts topline LEVEL ...

TENX - US Companies Moving the Markets, Evening edition
Wed, Feb 07, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States Palantir Technologies Inc. Class A (PLTR) rose 8.5% to $23.725 on volume of 224,436,172 shares MicroCloud Hologram Inc. (HOLO) rose 602.0% to $10.6 on volume of 173,635,213 shares Snap Inc. Class A (SNAP) fell 34.8% to $11.37 on volum...

TENX - Tenax Therapeutics, Equillium among healthcare movers

2024-02-07 10:00:01 ET More on Health Care Select Sector SPDR Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Lilly, Zoetis, Abbott least shor...

TENX - US Companies Moving the Markets, Morning edition
Wed, Feb 07, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Palantir Technologies Inc. Class A (PLTR) rose 30.8% to $21.87 on volume of 421,271,485 shares InVivo Therapeutics Holdings Corp. (NVIV) rose 136.9% to $0.526 on volume of 188,439,590 shares New York Community Bancorp Inc. (NYCB) fell...

TENX - Tenax surges after patent win for heart failure therapy

2024-02-06 13:37:49 ET More on Tenax Therapeutics Tenax falls as rally driven by IND clearance cools Tenax stock jumps after FDA greenlights studies for hypertension candidate Seeking Alpha’s Quant Rating on Tenax Therapeutics Historical earnings data ...

Previous 10 Next 10